🇺🇸 FDA
Patent

US 10130621

Analogs of pridopidine, their preparation and use

granted A61KA61K31/451A61P

Quick answer

US patent 10130621 (Analogs of pridopidine, their preparation and use) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/451, A61P, A61P25/00, A61P25/14